← Back to All Filings

Natera Insider Files Intent to Sell $3.4M in Stock via 10b5-1 Plan

Low SignificanceNovember 3, 2025 at 4:32:57 PM EST

Natera, Inc.

$NTRA144CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera Insider Files Intent to Sell $3.4M in Stock via 10b5-1 Plan

Company: Natera, Inc. (NTRA) Form: 144 | Filed: 2025-11-03 Significance: Low

Insider: Matthew Rabinowitz Title: Officer | Relationship: Director, Officer

Transaction: • Type: Proposed Sale • Shares: 17,100 • Price: ~$199.05 • Value: $3,401,703 • Owned After: Not Disclosed

Key Insight: The proposed sale represents a negligible fraction (0.012%) of the company's market cap and was filed under a pre-arranged 10b5-1 trading plan, reducing its significance as a market signal.

Market Context: This is a notice of intended sale, not a completed transaction. The filing also notes several other sales by the insider in the preceding three months, indicating a pattern of periodic selling.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An insider at Natera, Inc. has filed a notice of intent to sell approximately $3.4 million worth of common stock under a pre-established 10b5-1 trading plan.
  • Market Impact: The transaction is of low materiality, representing a negligible percentage of the company's market capitalization and public float, and is unlikely to have a meaningful impact on the stock price.

Company Information

FieldValue
CompanyNatera, Inc.
Ticker SymbolNTRA
CIK0001604821
IndustrySERVICES-MEDICAL LABORATORIES

Insider Information

FieldValue
NameMatthew Rabinowitz
CIK0001646382
Title/PositionOfficer
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-03 (Approximate)
Transaction CodeNot Applicable
Security TypeCommon Stock
Shares Involved17,100
Price Per Share~$199.05
Total Value$3,401,703
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$3,401,703
% of Market Cap0.012%
Shares Transacted17,100
% of Shares Outstanding0.012%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $27.30 billion, this $3.4 million proposed sale is financially immaterial.
  • Transaction Significance: The sale constitutes a very small fraction of both the market capitalization and the total shares outstanding, placing it well below any threshold for significance. The pre-planned nature of the sale further diminishes its importance as a trading signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is a notice of a proposed sale, not a completed one. Its small size relative to Natera's market cap and its execution under a 10b5-1 plan mean it is unlikely to influence market sentiment or stock price.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The number of shares is too small to significantly affect daily trading volume.
  • Sentiment Indicator: Neutral. Pre-planned sales by executives for financial planning are common and typically do not carry a strong bearish signal, especially when the size is minor.

Additional Context

Transaction Notes

  • Special Circumstances: The sale is being conducted pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025. This indicates the decision to sell was made months in advance and is not based on recent, non-public information.
  • Historical Context: The filing discloses several other sales by the insider and related trusts over the past three months, suggesting a consistent pattern of selling for liquidity or diversification purposes.
Topics:#SECFiling#InsiderTrading#NTRA#Natera#Form144#InsiderSell#StockMarket#Biotech#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.